Fludeoxyglucose f18

Fludeoxyglucose F18 is a radioactive diagnostic agent used in positron emission tomography (PET) scans to help detect and evaluate conditions like cancer, heart disease, and brain disorders. It's administered intravenously as an injection, with strengths ranging from 20-300 mCi/mL. Manufactured by UCSF Radiopharmaceutical Facility, it's a prescription drug approved under ANDA203902. This information was generated using AI and is provided for informational and research purposes only.